GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 19th Apr 2024 ADAP stock ended at $0.98. This is 8.72% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 17.39% from a day low at $0.92 to a day high of $1.08.
90 days $0.691 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2023-08-08 $0.86 $0.87 $0.85 $0.86 411 963
2023-08-07 $0.88 $0.91 $0.85 $0.86 953 257
2023-08-04 $0.89 $0.92 $0.88 $0.88 325 790
2023-08-03 $0.91 $0.91 $0.88 $0.88 237 465
2023-08-02 $0.90 $0.92 $0.88 $0.88 380 104
2023-08-01 $0.91 $0.95 $0.91 $0.91 487 203
2023-07-31 $0.91 $1.00 $0.91 $0.94 559 842
2023-07-28 $0.87 $0.91 $0.87 $0.89 232 483
2023-07-27 $0.93 $0.93 $0.87 $0.87 1 050 760
2023-07-26 $0.89 $0.93 $0.88 $0.93 270 189
2023-07-25 $0.92 $0.94 $0.88 $0.88 1 015 883
2023-07-24 $0.95 $0.96 $0.93 $0.94 382 088
2023-07-21 $0.95 $0.95 $0.91 $0.94 243 865
2023-07-20 $1.05 $1.05 $0.92 $0.94 1 072 158
2023-07-19 $0.95 $1.09 $0.93 $1.04 1 185 821
2023-07-18 $0.90 $0.95 $0.90 $0.95 896 549
2023-07-17 $0.90 $0.94 $0.89 $0.90 1 204 277
2023-07-14 $0.93 $0.94 $0.90 $0.90 721 769
2023-07-13 $0.93 $0.96 $0.93 $0.93 344 582
2023-07-12 $0.95 $0.96 $0.92 $0.93 488 211
2023-07-11 $0.93 $0.95 $0.92 $0.93 493 003
2023-07-10 $0.91 $0.94 $0.90 $0.93 1 097 143
2023-07-07 $0.93 $0.94 $0.90 $0.90 1 013 018
2023-07-06 $0.94 $0.96 $0.92 $0.93 531 925
2023-07-05 $0.93 $0.98 $0.93 $0.94 670 523
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT